Annual CFO
-$8.35 M
-$4.92 M-143.48%
31 December 2023
Summary:
Carmell Therapeutics Corporatio annual cash flow from operations is currently -$8.35 million, with the most recent change of -$4.92 million (-143.48%) on 31 December 2023. CTCX annual CFO is now -609.40% below its all-time high of -$1.18 million, reached on 31 December 2021.CTCX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$1.40 M
-$264.10 K-23.20%
30 September 2024
Summary:
Carmell Therapeutics Corporatio quarterly cash flow from operations is currently -$1.40 million, with the most recent change of -$264.10 thousand (-23.20%) on 30 September 2024. Over the past year, it has increased by +$2.58 million (+64.77%). CTCX quarterly CFO is now -619.65% below its all-time high of -$194.90 thousand, reached on 30 June 2022.CTCX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$7.03 M
+$2.58 M+26.84%
30 September 2024
Summary:
Carmell Therapeutics Corporatio TTM cash flow from operations is currently -$7.03 million, with the most recent change of +$2.58 million (+26.84%) on 30 September 2024. Over the past year, it has dropped by -$2.09 million (-42.35%). CTCX TTM CFO is now -3506.00% below its all-time high of -$194.90 thousand, reached on 30 June 2022.CTCX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTCX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -143.5% | +64.8% | -42.4% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
CTCX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -609.4% | at low | -619.6% | +64.8% | -3506.0% | +26.8% |
| 5 y | 5 years | -609.4% | at low | -619.6% | +64.8% | -3506.0% | +26.8% |
| alltime | all time | -609.4% | at low | -619.6% | +64.8% | -3506.0% | +26.8% |
Carmell Therapeutics Corporatio Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.40 M(+23.2%) | -$7.03 M(-26.8%) |
| June 2024 | - | -$1.14 M(+5.8%) | -$9.61 M(+7.4%) |
| Mar 2024 | - | -$1.08 M(-68.5%) | -$8.95 M(+7.2%) |
| Dec 2023 | -$8.35 M | -$3.41 M(-14.3%) | -$8.35 M(+69.1%) |
| Sept 2023 | - | -$3.98 M(+729.0%) | -$4.94 M(+136.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$480.20 K(+0.9%) | -$2.09 M(+15.8%) |
| Mar 2023 | - | -$476.00 K(-57.9%) | -$1.80 M(+35.9%) |
| Dec 2022 | -$3.43 M(+191.4%) | - | - |
| Sept 2022 | - | -$1.13 M(+479.5%) | -$1.32 M(+579.5%) |
| June 2022 | - | -$194.90 K | -$194.90 K |
| Dec 2021 | -$1.18 M | - | - |
FAQ
- What is Carmell Therapeutics Corporatio annual cash flow from operations?
- What is the all time high annual CFO for Carmell Therapeutics Corporatio?
- What is Carmell Therapeutics Corporatio annual CFO year-on-year change?
- What is Carmell Therapeutics Corporatio quarterly cash flow from operations?
- What is the all time high quarterly CFO for Carmell Therapeutics Corporatio?
- What is Carmell Therapeutics Corporatio quarterly CFO year-on-year change?
- What is Carmell Therapeutics Corporatio TTM cash flow from operations?
- What is the all time high TTM CFO for Carmell Therapeutics Corporatio?
- What is Carmell Therapeutics Corporatio TTM CFO year-on-year change?
What is Carmell Therapeutics Corporatio annual cash flow from operations?
The current annual CFO of CTCX is -$8.35 M
What is the all time high annual CFO for Carmell Therapeutics Corporatio?
Carmell Therapeutics Corporatio all-time high annual cash flow from operations is -$1.18 M
What is Carmell Therapeutics Corporatio annual CFO year-on-year change?
Over the past year, CTCX annual cash flow from operations has changed by -$4.92 M (-143.48%)
What is Carmell Therapeutics Corporatio quarterly cash flow from operations?
The current quarterly CFO of CTCX is -$1.40 M
What is the all time high quarterly CFO for Carmell Therapeutics Corporatio?
Carmell Therapeutics Corporatio all-time high quarterly cash flow from operations is -$194.90 K
What is Carmell Therapeutics Corporatio quarterly CFO year-on-year change?
Over the past year, CTCX quarterly cash flow from operations has changed by +$2.58 M (+64.77%)
What is Carmell Therapeutics Corporatio TTM cash flow from operations?
The current TTM CFO of CTCX is -$7.03 M
What is the all time high TTM CFO for Carmell Therapeutics Corporatio?
Carmell Therapeutics Corporatio all-time high TTM cash flow from operations is -$194.90 K
What is Carmell Therapeutics Corporatio TTM CFO year-on-year change?
Over the past year, CTCX TTM cash flow from operations has changed by -$2.09 M (-42.35%)